{"result": "(\"entity\"<|>ANTIÁCIDOS<|>ORGANIZATION<|>Antiácidos are medications that inhibit stomach acid production, which can affect iron absorption in the body.)\n##\n(\"entity\"<|>RANITIDINA<|>ORGANIZATION<|>Ranitidine is an antiacid medication that reduces stomach acid, potentially impacting iron absorption.)\n##\n(\"entity\"<|>OMEPRAZOL<|>ORGANIZATION<|>Omeprazole is a proton pump inhibitor used to decrease stomach acid, which may interfere with iron absorption.)\n##\n(\"entity\"<|>CLORANFENICOL<|>ORGANIZATION<|>Chloramphenicol is an antibiotic that can affect iron absorption in the body.)\n##\n(\"entity\"<|>TETRACICLINAS<|>ORGANIZATION<|>Tetracyclines are a class of antibiotics that may inhibit iron absorption.)\n##\n(\"entity\"<|>MICROCITOSIS<|>EVENT<|>Microcytosis is a condition characterized by smaller than normal red blood cells, often associated with iron deficiency.)\n##\n(\"entity\"<|>ANEMIA<|>EVENT<|>Anemia is a condition marked by a deficiency of red blood cells or hemoglobin, often linked to iron deficiency.)\n##\n(\"entity\"<|>SUPLEMENTOS DE HIERRO<|>ORGANIZATION<|>Iron supplements are used to treat iron deficiency and are crucial in managing conditions like anemia.)\n##\n(\"entity\"<|>EVALUACIÓN<|>EVENT<|>Evaluation is a process to determine the cause of iron deficiency and assess treatment effectiveness.)\n##\n(\"entity\"<|>ENDOSCOPIA<|>EVENT<|>Endoscopy is a medical procedure used to examine the digestive tract, often to rule out bleeding in cases of iron deficiency.)\n##\n(\"relationship\"<|>ANTIÁCIDOS<|>IRON<|>Antiácidos can inhibit the absorption of iron, affecting overall iron levels in the body<|>7)\n##\n(\"relationship\"<|>RANITIDINA<|>IRON<|>Ranitidine may reduce iron absorption due to its effect on stomach acid<|>6)\n##\n(\"relationship\"<|>OMEPRAZOL<|>IRON<|>Omeprazole can interfere with iron absorption by decreasing stomach acidity<|>6)\n##\n(\"relationship\"<|>CLORANFENICOL<|>IRON<|>Chloramphenicol may affect iron absorption in patients<|>6)\n##\n(\"relationship\"<|>TETRACICLINAS<|>IRON<|>Tetracyclines can inhibit the absorption of iron in the body<|>6)\n##\n(\"relationship\"<|>MICROCITOSIS<|>ANEMIA<|>Microcytosis is often a feature of anemia, particularly in cases of iron deficiency<|>8)\n##\n(\"relationship\"<|>SUPLEMENTOS DE HIERRO<|>ANEMIA<|>Iron supplements are commonly used to treat anemia caused by iron deficiency<|>9)\n##\n(\"relationship\"<|>EVALUACIÓN<|>ANEMIA<|>Evaluation is essential to determine the cause of anemia and guide treatment<|>8)\n##\n(\"relationship\"<|>ENDOSCOPIA<|>ANEMIA<|>Endoscopy may be performed to investigate potential causes of anemia, such as gastrointestinal bleeding<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: •  Evitar el abuso de fármacos que inhiben la absor-\npénica ante la magnitud del problema, y consiste en                              ción de hierro: antiácidos (ranitidina, omeprazol,\n---\n 414      BLOQUE: METABOLISMO\n\n\n\n      bicarbonato) y antibióticos (cloranfenicol y tetra-              por una cisteína en la posición 282 (C282Y) en los dos\n      ciclinas).                                                       alelos. El 5% de los pacientes con HH tipo 1 son homo-\n   •  La congelación y los tratamientos térmicos agresivos             cigotos compuestos (C282Y en un alelo y en el otro\n      disminuyen la absorción de hierro de carnes y pesca-             alelo la mutación H63D). En casos aislados, se han de-\n      dos al transformar el hierro hemo en no hemo.                    tectado otras mutaciones como la S65C, relacionada\n                                                                       con sobrecarga férrica cuando se asocia a la mutación\n   En la tabla 3 de detalla la cantidad de hierro en los               C282Y en el otro alelo25, 28 .\nprincipales grupos alimentarios\n1.9.   Resumen                                                         2.2.   Fisiopatología\n   La deficiencia de hierro representa la alteración nutri-               La ingestión ordinaria de hierro en la dieta occidental\ncional más frecuente a nivel mundial y constituye más                  es de unos 10-20 mg diarios, absorbiéndose aproxima-\nde la mitad de los casos de anemia. Los mecanismos fi-                 damente entre 1-2 mg en las personas sanas, mientras\nsiopatológicos son bien conocidos y ayudan a entender                  que los pacientes con HH pueden absorber de 3 a 6 mg\n                                                                       de hierro por día29. El hierro en la HH se acumula en el\nlas importantes consecuencias clínicas de la enferme-                  organismo a un ritmo aproximado de 0,5-1 gr/año, lle-\ndad. El diagnóstico viene determinado por unos niveles                 gando a alcanzar una sobrecarga de 5 e incluso 30 gr.\nbajos de hemoglobina asociados a microcitosis e hipo-                  de hierro en los casos más graves.\ncromia, entre otros, y es fundamental investigar la causa                 La característica principal de la HH es un incremento en\nprimaria. El tratamiento inicial consiste en suplementos               la absorción intestinal de hierro30. La homeostasis del hie-\nde hierro oral en los casos donde está claro el diagnósti-             rro depende estrechamente de las necesidades fisiológi-\nco etiológico, seguido de una adecuada evaluación si no                cas del organismo, que son aproximadamente de 1-2 mg\nexiste respuesta a este. En varones y mujeres postme-                  al día. La absorción de la forma iónica del hierro a través\nnopáusicas es aconsejable descartar hemorragia digesti-                del enterocito ocurre mediante dos pasos: en primer lu-\nva mediante endoscopia. El hierro intravenoso se reserva               gar, se produce la captación del hierro dietético a través\npara los casos severos de intolerancia o problemas de                  de la membrana apical y a continuación es transferido al\nabsorción con el hierro oral. La fortificación de alimen-              plasma a través de la membrana basolateral. Antes de la\ntos y las recomendaciones dietéticas son fundamentales                 captación, el hierro iónico requiere reducirse de la forma\npara la prevención de la enfermedad, pero no son sufi-                 férrica a la ferrosa, mediante las reductasas férricas que\ncientes en caso de anemia establecida, donde será pre-                 se expresan en la superficie luminal de los enterocitos\nciso añadir suplementos farmacológicos de hierro.                      duodenales. El hierro ferroso cruza la membrana apical\n                                                                       usando el transportador DMT1. El hierro captado por el\n2.   Hemocromatosis                                                    enterocito se almacena en su interior como ferritina y se\n2.1.   Introducción                                                    excreta con las heces o bien se transfiere a través de la\n                                                                       membrana basolateral al plasma mediante el transporta-\n   La hemocromatosis se define como el trastorno pro-                  dor denominado ferroportina, una vez que el hierro vuel-\nducido por la acumulación patológica de hierro en el                   ve a ser oxidado a su forma férrica por la ferroxidasa he-\norganismo. En la práctica clínica, este término se reser-              faestina. A continuación, el hierro pasa a la circulación,\nva para aquellas situaciones en las que la acumulación                 uniéndose a la transferrina. Esta última interacciona con\nde hierro es de causa genética (hemocromatosis here\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>HEMOCROMATOSIS<|>EVENT<|>Hemocromatosis is a disorder characterized by the pathological accumulation of iron in the body, often due to genetic causes.)\n##\n(\"entity\"<|>C282Y<|>PERSON<|>C282Y is a mutation associated with hereditary hemochromatosis, affecting iron absorption in patients.)\n##\n(\"entity\"<|>H63D<|>PERSON<|>H63D is another mutation related to hereditary hemochromatosis, which can occur alongside C282Y.)\n##\n(\"entity\"<|>IRON<|>ORGANIZATION<|>Iron is a vital nutrient that is absorbed in the body, with its levels being crucial for health, particularly in relation to hemoglobin levels.)\n##\n(\"entity\"<|>FERRITINA<|>ORGANIZATION<|>Ferritin is a protein that stores iron in the body, playing a key role in iron metabolism.)\n##\n(\"entity\"<|>DMT1<|>ORGANIZATION<|>DMT1 is a transporter that facilitates the absorption of ferrous iron across the intestinal membrane.)\n##\n(\"entity\"<|>FERROPORTINA<|>ORGANIZATION<|>Ferroportin is a transporter responsible for transferring iron from enterocytes to the plasma.)\n##\n(\"entity\"<|>TRANSFERRINA<|>ORGANIZATION<|>Transferrin is a protein that binds iron in the bloodstream and transports it to various tissues.)\n##\n(\"relationship\"<|>HEMOCROMATOSIS<|>C282Y<|>C282Y is a mutation that can lead to the development of hemocromatosis due to its effect on iron absorption<|>8)\n##\n(\"relationship\"<|>HEMOCROMATOSIS<|>H63D<|>H63D is a mutation that can contribute to hemocromatosis when present with C282Y<|>8)\n##\n(\"relationship\"<|>IRON<|>HEMOCROMATOSIS<|>Hemocromatosis involves the pathological accumulation of iron in the body<|>9)\n##\n(\"relationship\"<|>FERRITINA<|>IRON<|>Ferritin stores iron in the body, which is crucial for managing iron levels in conditions like hemocromatosis<|>7)\n##\n(\"relationship\"<|>DMT1<|>IRON<|>DMT1 is responsible for the absorption of ferrous iron in the intestines<|>6)\n##\n(\"relationship\"<|>FERROPORTINA<|>IRON<|>Ferroportin transfers absorbed iron from enterocytes to the bloodstream<|>6)\n##\n(\"relationship\"<|>TRANSFERRINA<|>IRON<|>Transferrin binds iron in the plasma and transports it to tissues, playing a role in iron homeostasis<|>7)\n<|COMPLETE|>"}]}